Can Mounjaro cause a low if it is my only diabetes medicine?

It is uncommon, because tirzepatide raises insulin mainly when blood sugar is high. In the SURPASS-1 trial of Mounjaro used alone, no one on tirzepatide had a reading below 54 mg/dL. The main risk comes from adding insulin or a sulfonylurea.

Is metformin with Mounjaro likely to cause lows?

Metformin is not an insulin secretagogue, and the Mounjaro label warning targets insulin and drugs like sulfonylureas. Lows are still possible if you eat very little or drink alcohol. Check with your care team about your own risk.

Should I stop my sulfonylurea when I start Mounjaro?

Do not stop or change it on your own. The label tells prescribers to consider lowering the sulfonylurea or insulin dose when Mounjaro starts. Your prescriber will decide based on your glucose readings.

What blood sugar number counts as low?

The American Diabetes Association defines low blood sugar as below 70 mg/dL. The Mounjaro label tracked readings below 54 mg/dL as clinically important lows. Your doctor may set a personal target.

Can I use a continuous glucose monitor while on Mounjaro?

Yes, NIDDK notes that continuous glucose monitors can show your glucose on a phone. A monitor can warn you of a falling level before symptoms start, which helps if you also take insulin or a sulfonylurea. Ask your care team whether one fits your plan.

Can Mounjaro Cause Low Blood Sugar With Insulin or a Sulfonylurea?

The short answer: Yes. Mounjaro (tirzepatide) rarely causes low blood sugar by itself, but the risk goes up when you also take insulin or a sulfonylurea such as glipizide or glimepiride. The FDA label warns that this combination can cause low blood sugar, including severe episodes. It says a lower dose of the insulin or sulfonylurea may be needed, a decision your prescriber makes.

Why does Mounjaro on its own rarely cause low blood sugar?

Tirzepatide acts on two gut hormone receptors, GIP and GLP-1. According to section 12.1 of the Mounjaro prescribing information, it boosts insulin release and lowers glucagon "in a glucose-dependent manner."

In plain terms, the drug pushes the pancreas to release more insulin mainly when blood sugar is high. As blood sugar falls toward normal, that push fades. This built-in brake is why lows are uncommon when Mounjaro is the only glucose-lowering drug.

The trial data back this up. In SURPASS-1, where Mounjaro was used alone for 40 weeks, the label reports that no one on any Mounjaro dose had a reading below 54 mg/dL. On placebo, 1% did. Nobody in any group had a severe low.

Insulin and sulfonylureas work differently. Insulin lowers blood sugar no matter what the level is. Sulfonylureas make the pancreas release insulin even when blood sugar is already normal. Add Mounjaro on top, plus eating less because of reduced appetite, and blood sugar can drop too far.

What does the Mounjaro label warn about insulin and sulfonylureas?

Hypoglycemia with these drugs is a formal warning in section 5.3 of the label. It says people who take Mounjaro with an insulin secretagogue (for example, a sulfonylurea) or with insulin "may have an increased risk of hypoglycemia, including severe hypoglycemia."

The label gives three points:

The risk "may be lowered by a reduction in the dose" of the sulfonylurea or insulin.
Section 7.1 tells prescribers to "consider reducing the dose" of these drugs when Mounjaro is started.
Patients on these combinations should be taught the signs and symptoms of low blood sugar.

The label does not give a set amount to cut. That choice depends on your current doses, your glucose readings, and how your body responds. Do not change insulin or sulfonylurea doses on your own. Ask your prescriber for a plan before your first injection and before each dose step. Our Mounjaro dosing schedule guide explains how the weekly doses go up over time.

How often did low blood sugar happen in the SURPASS trials?

The label reports low blood sugar in two ways. "Blood glucose below 54 mg/dL" counts readings at that level. "Severe hypoglycemia" means an episode where someone else had to give carbohydrate, glucagon, or other help.

With basal insulin (SURPASS-5). This 40-week trial added Mounjaro or placebo to insulin glargine, with or without metformin. The insulin dose was adjusted toward a fasting target below 100 mg/dL. The label reports readings below 54 mg/dL in:

13% on placebo
16% on Mounjaro 5 mg
19% on Mounjaro 10 mg
14% on Mounjaro 15 mg

Severe lows occurred in 0%, 0%, 2%, and 1% of those groups. Note that the placebo group also had lows, because insulin itself causes them.

With a sulfonylurea (SURPASS-4). The label says lows were "more frequent" when Mounjaro was used with a sulfonylurea. SURPASS-4 ran up to 104 weeks and enrolled 2,002 adults with type 2 diabetes and higher heart risk. About 54% took a sulfonylurea as background therapy. Among people taking a sulfonylurea, readings below 54 mg/dL occurred in 13.8%, 9.9%, and 12.8% on 5, 10, and 15 mg. Severe lows occurred in 0.5%, 0%, and 0.6%.

SURPASS-2 and SURPASS-3 are sometimes described as sulfonylurea trials, but they were not. The label shows SURPASS-2 added Mounjaro to metformin alone. SURPASS-3 added it to metformin with or without an SGLT2 inhibitor.

What are the signs of low blood sugar?

The American Diabetes Association defines low blood sugar as a level below 70 mg/dL. The NIDDK says symptoms tend to come on quickly and vary from person to person. Mild to moderate signs include:

Feeling shaky, jittery, hungry, or tired
Dizziness, lightheadedness, confusion, or irritability
A fast or uneven heartbeat
Headache, or trouble seeing or speaking clearly

When the level is very low, a person can lose consciousness or have a seizure. NIDDK also notes that lows can happen during sleep. Signs include nightmares, crying out, damp sheets from sweating, or waking up tired or confused.

Some Mounjaro side effects overlap with these signs. Nausea, poor appetite, and fatigue are common early on. If you feel off and you take insulin or a sulfonylurea, check your glucose rather than guess. Our side effects guide covers the stomach symptoms.

How do you treat a low, and when is glucagon needed?

The ADA calls this the 15-15 rule. NIDDK gives these steps when your level is below your target or below 70 mg/dL:

Take 15 to 20 grams of fast-acting carbohydrate. Examples are 4 glucose tablets, 1 tube of glucose gel, half a cup of regular juice, or 1 tablespoon of sugar or honey.
Wait 15 minutes and check again.
If you are still low, repeat the step.
Once you are back in range, eat a snack if your next meal is more than an hour away.

Carry glucose tablets or a juice box. Reduced appetite on Mounjaro can mean smaller or skipped meals, which raises the risk.

Severe lows need someone else's help. NIDDK calls glucagon "the best way to treat severely low blood glucose." It comes as an injection or a nasal spray. Ask your doctor whether you should have a kit, and teach family or coworkers how to use it. NIDDK says to call 911 right after giving glucagon, or if no kit is on hand.

Alcohol adds risk too. NIDDK notes it can lower blood sugar and hide the first warning signs. See our page on Mounjaro and alcohol.

Is it safe to drive if you take Mounjaro with insulin or a sulfonylurea?

Most people can drive safely, but a low behind the wheel is dangerous. An American Diabetes Association position statement on diabetes and driving says even moderate lows impair driving and judgment. Its practical advice for people at risk:

Check blood glucose before driving, and at regular intervals on trips longer than 30 to 60 minutes.
Keep a meter and fast-acting carbohydrate in the car.
If you go low, treat it and do not drive until your level is back in a safe range. That usually takes 30 to 60 minutes, because thinking recovers more slowly than glucose.

Tell your doctor if you stop noticing the early signs of lows. The statement flags reduced awareness as a reason to review driving safety.

The bottom line

Mounjaro alone seldom causes low blood sugar because its effect on insulin depends on glucose levels. Insulin and sulfonylureas do not have that brake, so the combination can push glucose too low. The label warns about this and says those doses may need to come down. Learn the signs, use the 15-15 rule, ask about glucagon, and check before you drive. Other GLP-1 drugs carry similar warnings, covered on glp1.md.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk to your prescriber before changing any insulin or diabetes medicine dose.